Search result for pharmaceutical
In India, Bayer confronts a shortage of the contraceptive pill Yasmin
Bayer, a German pharmaceutical company, stated that it was experiencing supply issues with its popular oral contraceptive pill Yasmin in India and that supply would recommence in the "next few days".
Since March, approximately forty Indian pharmacies and drug distributors have...
Pfizer shareholders may finally get the bargain of their dreams in Seagen.
The cancer drug maker's innovative approach makes it an attractive acquisition candidate for a pharmaceutical behemoth. According to reports, pharmaceutical giant Pfizer Inc. is negotiating an acquisition that would please the company's investors. The Wall Street Journal reported last nig...
Pharmaceutical reported top-line growth and a return to profitability on the bottom line
Gulf Pharmaceutical Industries (Julphar), situated in Ras Al Khaimah (RAK), has released its financial results for 2021. The firm recorded sales of Dhs1,143m, a 100% increase over the Dhs573m received in 2020.
The pharma firm credited the considerable gain to increasing market share in ...
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market to Witness 8.7% Growth during 2021 - 2029
The Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is projected to grow at a CAGR of 8.7% during the forecast period (2021 – 2029). The global pharmaceutical contract sales outsourcing (CSO) market is driven by the changing nature of the pharmaceutical industry with new...
Global Radiopharmaceutical Theragnostic Market was valued at US$ 1123.42 Mn in 2020 and is Projected to Grow at a CAGR of 15.83% over the Forecast Period
Rising Demand for Targeted Cancer Treatment
Cancer arises from the transformation of normal cells into tumor cells in a multi-stage process that generally progresses from a pre-cancerous lesion to a malignant tumor. Cancer pain can arise due to tumor compressing or infi...
Global Active Pharmaceutical Ingredient Market to Grow at Promising
The global active pharmaceutical ingredient market reached a robust valuation of US$ 172.14 billion in 2020. The market will exhibit strong growth, rising at 6% CAGR during the forecast (2021-2029) period. Companies such as Sanofi planned to create a major European company dedicated to the produc...
Global Pharmaceutical Quality Control Market was Valued at
Absolute Markets Insights (AMI) reports a robust forecast for the pharmaceutical quality control market during the 2021-2029 period. In its newly released report, AMI anticipates the market will grow at 13.85% as minimized disruption, transit time and costs are rapidly leading the market towards ...
INDIAN GOVERNMENT FIRMS PREPARE TO MANUFACTURE COVAXIN
HIGHLIGHTS
- Indian Government firms are preparing to manufacture Covaxin.
- Covaxin was first developed with seed strains received from the National Institute of Virology (NIV).
- Phase 3 clinical trial of Covaxin was co-funded by ICMR. <...
JAPAN PHARMACEUTICAL ASSOCIATION OPPOSES TEMPORARY WAIVER OF PATENT ON VACCINE
Highlights –
- Japan pharmaceutical association opposes temporary waiver of patent on vaccine.
- It opposed U.S support for the temporary waiver of coronavirus vaccine patent rights.
- WTO is currently discussing the waiver of patent rights...
CHINA TO PRODUCE COVID-19 VACCINE FOR 70% OF ITS POPULATION
Highlights –
- China to produce COVID-19 vaccine for 70% of its population.
- China is trying to reshape its pharmaceutical industry.
- More than 100 million doses had been exported by March.
- Biotec has produced 250 million doses...
SAMSUNG BIOLOGICS BUILDING NEW PLANT FOR FUTURE GROWTH ENGINES
Highlights –
- Samsung Biologics building new plant for future growth engines.
- The company will produce and manufacture biopharmaceutical products for major pharmaceutical firms.
- The new upcoming plant is said to be worth $1.4 billion.<...
CELLTRION WILL SUPPLY ITS COVID-19 TREATMENT WITHOUT PROFIT MARGIN IN S. KOREA
Highlights –
- Celltrion will supply its COVID-19 treatment without profit margin in S. Korea.
- Celltrion’s CT-P59 began to be supplied to local medical institutions on Wednesday.
- The company has also planned to supply the treatmen...
CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT
Highlights –
- Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
- The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
- The company has also t...
JAPAN’S KOBAYASHI KAKO CO. RECEIVES AN ORDER TO SUSPEND BUSINESS FOR 116 DAYS
Highlights –
- Japan’s Kobayashi Kako Co. receives an order to suspend business for 116 days.
- The company was guilty of making fictitious production records on nearly 80 percent of its products.
- The company last year had recalled ...
PHARMACEUTICAL STRATEGY OF EUROPEAN COMMISSION HAILED BY HEALTHCARE DISTRIBUTORS
Highlights:
- The pharmaceutical strategy of the European Commission has been hailed by the distributors of Healthcare
- The strategy is aiming to make sure that, the patients have the access to the affordable and innovative medicines
As...
WARREN BUFFET'S BERKSHIRE HATHWAY INVESTS HUGE MONEY IN US PHARMA COMPANIES
Highlights
• Berkshire Hathaway, the investment company owned by Warren Buffet has decided to place its bets on pharmaceutical companies in the U.S.
• According to the Bloomberg Billionaires Index, courtesy of these investments, the net worth of Buffet surged to $88 ...
SAMSUNG BIOLOGICS BROADENS HORIZONS WITH INSTALLATION BASE IN SAN FRANCISCO
- Samsung Biologics has opened its first overseas installation in San Francisco as part of the contract policy and manufacturing organization's efforts to provide an unparalleled service network to more than 2,500 life science and biotechnology firms in the city.
- Also at the ...
BACTERIAL INFECTION PLAGUES NORTHWEST CHINA IN SEVERE OUTBREAK FROM BIOPHARMA LEAK
- Several thousand people in northwest China took being plagued with a bacterial disease by testing positive for it, authorities said on Tuesday, in a massive outbreak caused by a leak at a biopharmaceutical company last year.
- The Health Advisory of Lanzhou, the capital of Gansu ...
TAKEDA AIMS TO GO PUBLIC IN THE NEXT 5 TO 10 YEARS AFTER BLACKSTONE’S ACQUISITION
Highlights –
- Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
- The unit needs to expand its business overseas in Chinese-speaking markets.
- Takeda plans to sell its drug unit to Bl...
TAKEDA CO. PLANNING TO SELL ITS OTC MEDICINE UNIT TO U.S BLACKSTONE GROUP INC.
Highlights –
- Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
- Takeda plans on selling the same for around $2.9 billion.
- Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.